Immuron’s CEO Steven Lydeamore will present at Peak’s Management Conference and highlight:
💊 Therapeutic drug candidates
📔 Product portfolio
👊 Outlook
Watch the full interview ⚡ https://youtu.be/HkgvbT3cRu8
MTL
0.002
100%
4DS
0.01
-64.3%
KRR
0.011
57.1%
CZN
0.002
-33.3%
CHM
0.003
50%
TMK
0.002
-33.3%
LAT
0.065
38.3%
M4M
0.007
-22.2%
ANR
0.011
37.5%
QXR
0.004
-20%
AMS
0.012
33.3%
RC1
0.008
-20%
RNX
0.004
33.3%
SIS
0.004
-20%
SP3
0.032
33.3%
SPQ
0.004
-20%
CXU
0.009
28.6%
MGT
0.065
-18.8%
PEK
0.42
25.4%
THR
0.01
-16.7%
BYH
0.005
25%
VAR
0.005
-16.7%
FBR
0.005
25%
SNS
0.069
-15.9%
MRQ
0.005
25%
KCCDA
0.85
-15%
OEL
0.005
25%
EMU
0.023
-14.8%
XGL
0.028
21.7%
EM2
0.006
-14.3%
GML
0.063
21.2%
SPX
0.006
-14.3%
GLA
0.029
20.8%
WOA
0.013
-13.3%
BSN
0.047
20.5%
POD
0.04
-13%
MVL
0.018
20%
ESR
0.028
-12.5%
ZMM
0.018
20%
PET
0.007
-12.5%
